- Home
- CRVO vs NTRB Comparison
CRVO vs NTRB Comparison
Compare CRVO & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVO
- NTRB
- Stock Information
- Founded
- CRVO 2001
- NTRB 2016
- Country
- CRVO United States
- NTRB United States
- Employees
- CRVO N/A
- NTRB N/A
- Industry
- CRVO Biotechnology: Pharmaceutical Preparations
- NTRB Industrial Specialties
- Sector
- CRVO Health Care
- NTRB Health Care
- Exchange
- CRVO Nasdaq
- NTRB Nasdaq
- Market Cap
- CRVO 67.4M
- NTRB 59.1M
- IPO Year
- CRVO N/A
- NTRB N/A
- Fundamental
- Price
- CRVO $5.56
- NTRB $10.72
- Analyst Decision
- CRVO Strong Buy
- NTRB Buy
- Analyst Count
- CRVO 8
- NTRB 1
- Target Price
- CRVO $25.57
- NTRB $13.00
- AVG Volume (30 Days)
- CRVO 137.9K
- NTRB 115.7K
- Earning Date
- CRVO 08-08-2025
- NTRB 05-30-2025
- Dividend Yield
- CRVO N/A
- NTRB N/A
- EPS Growth
- CRVO N/A
- NTRB N/A
- EPS
- CRVO N/A
- NTRB N/A
- Revenue
- CRVO $9,308,215.00
- NTRB $2,398,437.00
- Revenue This Year
- CRVO N/A
- NTRB $560.75
- Revenue Next Year
- CRVO N/A
- NTRB $588.39
- P/E Ratio
- CRVO N/A
- NTRB N/A
- Revenue Growth
- CRVO 15.14
- NTRB 18.92
- 52 Week Low
- CRVO $1.80
- NTRB $3.72
- 52 Week High
- CRVO $20.63
- NTRB $11.78
- Technical
- Relative Strength Index (RSI)
- CRVO 30.87
- NTRB 81.37
- Support Level
- CRVO $6.31
- NTRB $7.52
- Resistance Level
- CRVO $7.20
- NTRB $8.41
- Average True Range (ATR)
- CRVO 0.53
- NTRB 0.61
- MACD
- CRVO -0.10
- NTRB 0.14
- Stochastic Oscillator
- CRVO 0.00
- NTRB 79.51
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.